Table 4 Rate of long-term follow-up Major adverse cardiac events and Odds ratios in the patient subgroups

Sex

   male

7/235 (3.2)

3/88(3.4)

0.9(0.2–3.4)

9/143(6.3)

0.5 (0.2–1.2)

   female

4/103 (3.9)

0/23

-

3/68(4.4)

0.9(0.2–4.0)

Diabetes mellitus

   Yes

1/66(1.5)

0/28

-

4/52(7.7)

0.2(0.1–1.7)

   No

10/373(3.6)

3/82(3.7)

1.0(0.3–3.8)

8/157(5.1)

0.7(0.3–1.9)

Prior PCI

   Yes

0/12

0/11

-

0/6

-

   No

11/326(3.3)

3/100(3.0)

1.1(0.4–4.1)

12/205(5.9)

0.6(0.2–1.3)

Drug-eluting stents

   Yes

2/83(2.4)

0/6

-

1/37(2.7)

0.8(0.1–9.5)

   No

9/260(3.5)

3/100(3.0)

1.2(0.4–4.5)

11/169(6.5)

0.6(0.2–1.4)

Angulated segments

   Yes

0/7

0/16

-

0/15

-

   No

11/331 (3.3)

3/95(3.2)

1.1(0.3–3.8)

12/196(6.2)

0.5(0.3–1.2)

Stent length

   <20 mm

10/270(3.7)

3/94(3.2)

1.2(0.4–4.3)

8/146(5.4)

0.7(0.3–1.8)

   >20 mm

1/68(1.5)

0/1

-

4/55(7.3)

0.2(0.1–1.7)

Stent diameter

   <3 mm

6/73(8.2)

0/15

-

7/97(7.2)

1.4(0.4–4.4)

   >3 mm

5/260(1.9)

3/98(3.1)

0.6(0.1–2.6)

5/100(5.0)

0.4(0.1–1.4)